Sequenom Posts 13 Percent Rise in Q4 Revenues, Reports Profitability for FY 2014 | GenomeWeb

This story has been updated from a previous version to include comments from Sequenom's earnings call.

NEW YORK (GenomeWeb) – Consistent with its preannouncement in January, Sequenom reported after the close of the market today that its fourth quarter revenues increased 13 percent year over year.

It reported revenues of $36.8 million for the three months ended Dec. 31, up from $32.7 million in Q4 2013, but falling short of analysts' average estimate of $41.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.